$DVA

3 Surging Stocks That Don’t Need the AI Boom to Keep Winning

DaVita (DVA), Franklin Resources (BEN), and Archer Daniels Midland (ADM) have each gained over 30% YTD. DVA benefits from improved reimbursement rates and cost discipline, with analysts projecting 18% earnings growth. BEN has moderated outflows and beaten earnings estimates. ADM raised guidance despite volatile global trade conditions.

Original reporting
Published Sep 22, 2026, 9:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$DVA
Bullish
high confidence
Mentioned
$DVA · $BEN · $ADM
Relevance
6/10
AlphAI data visualization · based on yahoo.com
Decision brief

The 30-second read

$DVABullishMed
01

Why it matters

Strong earnings beats and guidance upgrades suggest continued upside, offering diversification away from AI‑centric themes.

02

Market read

These three firms demonstrate that solid fundamentals can drive significant returns even without AI exposure.

03

What to watch

Potential regulatory or macro‑economic headwinds could temper the upside despite strong guidance.

Relevance 6/10Novelty 6/10Timing: current 2026 YTD performance

Background

The article highlights three non‑AI stocks that have outperformed YTD, emphasizing earnings guidance and operational improvements.

Company-level read

Ticker impact

$DVABullishHigh confidence
Context

DaVita reaffirmed its full‑year guidance after a strong Q2 2026, supporting its 30%+ YTD rally.

Expected impact

Continued upside pressure, potential further 10‑15% gain.

Evidence & confidence

Guidance reaffirmation and cost discipline signal earnings growth of >18% YoY.

$BENBullishMedium confidence
Context

Franklin Resources posted a 6‑cent EPS beat and 14% revenue growth, tempering outflows and boosting YTD performance.

Expected impact

Likely modest rally, 5‑8% upside in coming weeks.

Evidence & confidence

Better‑than‑expected earnings and moderated outflows improve outlook.

$ADMBullishHigh confidence
Context

Archer Daniels Midland raised its full‑year adjusted EPS guidance by about $1 and posted strong grain‑processing volumes, fueling a 48% YTD rise.

Expected impact

Potential 8‑12% upside as market digests higher EPS outlook.

Evidence & confidence

Guidance lift and operational beat indicate robust earnings trajectory.

Market effects

Healthcare, asset management, and agribusiness sectors gain confidence from strong earnings and guidance lifts.

U.S. equities benefit from diversified non‑AI growth drivers.

Shows that non‑AI stocks can outperform in a market dominated by AI hype.

Counterpoint

If AI‑driven momentum reverses, these non‑AI stocks may face relative underperformance.

Key entities

  • DaVita Inc.

    Dialysis provider with reaffirmed guidance.

  • Franklin Resources Inc.

    Asset manager with earnings beat.

  • Archer Daniels Midland Co.

    Agribusiness with raised EPS guidance.

Related articles

$BENMed

Franklin Templeton brings its tokenized collateral service to Bybit

Franklin Templeton has expanded its tokenized collateral service to Bybit, allowing users to pledge shares in its tokenized money market funds, worth $686 million, as collateral for USDT or USDC trading credit lines while earning yield. The underlying assets are held off-exchange by ByCustody, with the value mirrored in Bybit's trading environment. This follows similar partnerships with Binance and OKX.

$ADMMed

ADM’s Infant Probiotic Trial: A New Data Catalyst In Consumer Health

Archer-Daniels-Midland (ADM) completed a clinical trial testing a probiotic for infant colic relief. The double-blinded, placebo-controlled study aims to support ADM's position in science-backed nutrition. Positive results could boost ADM's pediatric nutrition sales and stock sentiment. The trial was updated on September 22, 2026, with data analysis underway.

$CNCMed

2 Non-AI Giants to Buy on Solid Guidance and Lucrative Valuation

Centene Corp. (CNC) and Archer-Daniels-Midland Co. (ADM) are highlighted for strong performance and attractive valuations. CNC expects 2026 revenues of $173-$177B and adjusted EPS over $4.80, with a forward P/E of 13.58X. ADM raised 2026 adjusted earnings guidance to $5.15-$5.60 per share, with a forward P/E of 16.60X.

$BENMedAI 8/10

Franklin Templeton Acquires Majority Stake Stoneshield

Franklin Templeton's Clarion Partners will acquire a majority stake in Stoneshield Capital, tripling its European AUM to $13B and boosting total alternative AUM above $300B. Stoneshield, with $9B in AUM, specializes in European real assets. The deal is expected to close in Q4 2026, expanding Clarion's European footprint and investment strategies.

$ADMMedAI 8/10

SEC Produces 307,000 Documents in Fraud Case Against Former ADM CFO

The SEC has produced 307,000 documents in its fraud case against former ADM CFO Vikram Luthar, with ongoing document production. The case involves alleged inflation of ADM's Nutrition business performance. ADM settled related charges with a $40M penalty. Discovery is expected to continue until March 2027. Luthar is contesting the allegations in court.